Anti-Ms NK1.1 PE

*Carlyle JR, Mesci A, Ljutic B, Belanger S, Tai LH, Rousselle E, Troke AD, Proteau MF, Makrigiannis AP: Molecular and genetic basis for strain-dependent NK1.1 alloreactivity of mouse NK cells. J Immunol. 2006 Jun 15;176 (12) :7511-24., URL: http://www.ncbi.nlm.nih.gov/pubmed/16751398 , *GeurtsvanKessel CH, Bergen IM, Muskens F, Boon L, Hoogsteden HC, Osterhaus AD, Rimmelzwaan GF, Lambrecht BN: Both conventional and interferon killer dendritic cells have antigen-presenting capacity during influenza virus infection. PLoS One. 2009 Sep 28;4 (9) :e7187. , URL: http://www.ncbi.nlm.nih.gov/pubmed/19784375 , *Símová J, Bubeník J, Bieblová J, Jandlová T: The role of NK1.1+ cells in the protection against MHC class I+ HPV16-associated tumours. Folia Biol (Praha) . 2004;50 (6) :200-2., URL: http://www.ncbi.nlm.nih.gov/pubmed/15709715 , *Carroll JL, Nielsen LL, Pruett SB, Mathis JM: The role of natural killer cells in adenovirus-mediated p53 gene therapy. Mol Cancer Ther. 2001 Nov;1 (1) :49-60., URL: http://www.ncbi.nlm.nih.gov/pubmed/12467238 , *Joncker NT, Shifrin N, Delebecque F, Raulet DH: Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment. J Exp Med. 2010 Sep 27;207 (10) :2065-72., URL: http://www.ncbi.nlm.nih.gov/pubmed/?term=mature+natural+killer+cells+reset , *Wang M, Ellison CA, Gartner JG, HayGlass KT: Natural killer cell depletion fails to influence initial CD4 T cell commitment in vivo in exogenous antigen-stimulated cytokine and antibody responses. J Immunol. 1998 Feb 1;160 (3) :1098-105., URL: http://www.ncbi.nlm.nih.gov/pubmed/9570522 , *Takahashi S, Kawamura T, Kanda Y, Taniguchi T, Nishizawa T, Iiai T, Hatakeyama K, Abo T: Activation of CD1d-independent NK1.1+ T cells in the large intestine by Lactobacilli. Immunol Lett. 2006 Jan 15;102 (1) :74-8., URL: http://www.ncbi.nlm.nih.gov/pubmed/16107279 , *Fang M, Lanier LL, Sigal LJ: A role for NKG2D in NK cell-mediated resistance to poxvirus disease. PLoS Pathog. 2008 Feb 8;4 (2) :e30., URL: http://www.ncbi.nlm.nih.gov/pubmed/18266471 , *Kulesza J, Hoser G, Wasilewska D, Kawiak J: NK cell depletion and recovery in SCID mice treated with anti-NK1.1 antibody. Folia Histochem Cytobiol. 2006;44 (2) :93-6., URL: http://www.ncbi.nlm.nih.gov/pubmed/?term=kulesza+j+hoser+g , *Laffont S, Seillet C, Ortaldo J, Coudert JD, Guéry JC: Natural killer cells recruited into lymph nodes inhibit alloreactive T-cell activation through perforin-mediated killing of donor allogeneic dendritic cells. Blood. 2008 Aug 1;112 (3) :661-71, URL: http://www.ncbi.nlm.nih.gov/pubmed/18505782

The mouse monoclonal antibody PK136 recognizes an extracellular epitope of NK1.1 antigen (NK cell marker) expressed by some mouse strains (e.g. C57BL/6, NZB, CE, C58, Ma/My), whereas other strains (e.g. BALB/c, AKR, CBA, C3H) do not express this antigen. This antibody detects a conformational epitope on Nkrp1c and Nkrp1b gene products.